DrugRisk Legal News Adds Latest Court Order In NuvaRing Claims

The DrugRisk Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to visit DrugRisk or speak with a lawyer about their legal rights as soon as possible.

Kansas City, MO (PRWEB) January 24, 2014

The birth control safety advocates at DrugRisk.com have added updated legal news for patients using the contraceptive NuvaRing. A federal court has ordered that lawsuits alleging the device caused blood clots be placed on hold while parties try to reach a resolution*.

The DrugRisk Center is a free resource for patients who use popular prescription drugs or medical devices. Visitors can find the latest news, safety alerts, product recalls and litigation updates. They can also see if others are experiencing similar side effects and decide if they need legal advice.

The NuvaRing contraceptive is a small plastic vaginal ring insert approved by the FDA for sale in the United States in 2001. Today it is marketed in over 50 countries and used by an estimated 1.5 million people worldwide**.

DrugRisk has added warnings from health experts like the New England Journal of Medicine showing vaginal ring contraceptives like NuvaRing may result in a 6.5 times increased risk of blood clots***.

A number of women have already filed a NuvaRing lawsuit against Merck alleging blood clots from the device, with many cases consolidated to a special federal multidistrict litigation court. The formal case is In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. The latest court records show 1,658 cases filed as of January 15****.

Now, the resource center has learned that the court recently issued an order postponing the start of the first trial and placing legal action on hold through May 31st to give the parties additional time to try to reach a settlement.*

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to visit DrugRisk or speak with a lawyer about their legal rights as soon as possible. DrugRisk only recommends lawyers who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Judge Rodney Sippel, 1/9/14; http://www.aboutlawsuits.com/wp-content/uploads/2014-01-09-NuvaRing-Trial-Order.pdf & http://www.aboutlawsuits.com/wp-content/uploads/2013-01-09-NuvaRing-Stay.pdf
**Huffington Post, 12/18/13; huffingtonpost.com/2013/12/18/nuvaring-blood-clots_n_4461429.html
***New England Journal of Medicine, 6/14/12; nejm.org/doi/full/10.1056/NEJMoa1111840
****Judicial Panel on Multidistrict Litigation, 1/15/14; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-January-15-2014.pdf


Contact